Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2022 | Story Anthony Mthembu | Photo Victor Ramphore Mahlohla (baddapictures)
Inaugural Dreamwalk 2022
The inaugural dream walk put students in high spirits for the rest of the year, as they were able to express and celebrate their dreams and aspirations.

The inaugural dream walk at the University of the Free State took place on the Bloemfontein Campus on 19 February 2022. The dream walk, also referred to as ‘Leeto la ditoro’, will become an annual event where first-year students come together to express and celebrate their dreams and aspirations. 

The event was well attended by Bloemfontein Campus first-year students, who believe that the event is a great way to set the tone for the rest of the year. The students first gathered at a station on campus, where they were issued with a faculty T-shirt, key chain, a dream card, and a mask. The official walk then began from the Visitor Centre Gate on the northwest side of the Bloemfontein Campus to the Main Building, where members of the senior leadership are based.
During the walk, first-year students had to write down their dreams and aspirations on the dream card, which they ultimately placed in a box at the Main Building. “I found it amazing to be able to put my dreams on paper; it makes them more realistic,” highlighted Marise Prinsloo, a first-year student from the Outeniqua residence. Although some of the aspirations were too personal for some first-year students to speak about, others’ aspirations varied from academic success, spiritual wellness, and mental and physical health. In fact, Malcolm Willemse, who is also a first-year student from Outeniqua, hopes to secure a number of leadership positions. “I have dreams of being in the first-year committee and of being in the sub-committees, and I managed to write these down,” he shared. 

In addition, the atmosphere at the event was vibrant, as the students were excited to engage with one another. “It was amazing to walk with other residences such as Villa Bravado, Abraham Fischer, and Conlaurês, as they have great spirit,’’ expressed Willemse. The walk included songs from the various residences, and the first-year students were dancing and singing along. However, the fun did not end there. Once the students arrived at the Main Building, they were treated to a DJ who had them dancing and singing even more.

As the dream walk event will also take place on the Qwaqwa and South Campuses, the students on these campuses can expect to take part in a lot of singing, dancing, and other cultural activities. Precious Modiba, who is also a first-year student, argues that besides having a good time, one of the best things about the dream walk is the friends that one gets to make.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept